← Open Payments lookup

TERRY JORDAN: Open Payments

NPI 1417046327 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,276 in 63 payments from 11 companies in 2025. Trend: 2023 $650 · 2024 $908 · 2025 $1,276

Food & beverage: $1,276
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$300
ABBVIE INC.12$229
Neurocrine BioSciences, Inc.7$144
E.R. Squibb & Sons, L.L.C.7$126
Vanda Pharmaceuticals Inc.4$96
Teva Pharmaceuticals USA, Inc.4$85
Otsuka America Pharmaceutical, Inc.5$83
Axsome Therapeutics, Inc.4$74
Lundbeck LLC3$61
Janssen Pharmaceuticals, Inc3$56

Products named: CAPLYTA, VRAYLAR, INGREZZA, COBENFY, FANAPT, REXULTI, AUSTEDO XR, Auvelity.

Industry payments across MS — which companies pay providers there.